Marjac - According to the article quote:
Hikma spokesperson Steven Weiss said in an email. "Most important, we are continuing to manufacture and provide this important medicine to the millions of patients who need it."
'providing this important medicine to millions of people's," while numerous Generic manufacturers are selling the same product is telling, because the indication they're going after isn't big enough to supply such quantities, especially from one player in the GV space. It clearly shows clear intent to pursue the larger CVD market.
ILT